Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rangering i aksjer #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aksjekurs
$0.37430781
Sist synkronisert: 2026-08-19
Markedsverdi
$28.37M
Endring (1 dag)
2.00%
Endring (1 år)
-13.46%
Land
CA
Handel Defence Therapeutics Inc. (DTC)

Kategori

Aksjeprishistorikk for Defence Therapeutics Inc. (DTC)
Høyeste sluttskurs: $0.32 den 2026-08-01

Laveste sluttskurs: $2.94 den 2021-05-01
Aksjeprishistorikk for Defence Therapeutics Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -20.25%
2025 47.28%
2024 -78.72%
2023 11.75%
2022 -62.63%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.22 -13.24%
AU
$753.28 5.84%
CH